| Q28365449 | A comparison of left ventricular abnormalities associated with glucose intolerance in African Caribbeans and Europeans in the UK |
| Q50531488 | A comparison of ultrastructural changes on endomyocardial biopsy specimens obtained from patients with diabetes mellitus with and without hypertension. |
| Q44510083 | Alteration in haemodynamics and pathological changes in the cardiovascular system during the development of Type 2 diabetes mellitus in OLETF rats |
| Q74578659 | An IDDM patient who complained of chest oppression with ischemic changes on ECG in insulin-induced hypoglycemia |
| Q72848873 | Angioarchitecture in the heart of rats with streptozotocin-induced diabetes mellitus |
| Q67601718 | Appropriate Blood Pressure Control in type II diabetes (ABCD Trial): implications for complications |
| Q28326605 | Beneficial effects of diltiazem on the natural history of hypertensive diabetic cardiomyopathy in rats |
| Q24562618 | Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart |
| Q35816827 | Cardiac pathology in the hypertensive diabetic rat. Biventricular damage with right ventricular predominance |
| Q33606262 | Cardiomyopathy in diabetic patients. |
| Q69567035 | Clinical studies on diabetic myocardial disease using exercise testing with myocardial scintigraphy and endomyocardial biopsy |
| Q71064580 | Coronary artery disease in diabetic and nondiabetic patients: a clinical and angiographic comparison |
| Q35857956 | Coronary microvascular abnormalities in the hypertensive-diabetic rat. A primary cause of cardiomyopathy? |
| Q72189534 | Diabetic cardiomyopathy |
| Q34245190 | Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies |
| Q30457504 | Diabetic cardiomyopathy: pathophysiology and clinical features |
| Q38708544 | Diabetic heart disease: the clinical and pathological spectrum--Part I. |
| Q30408455 | Diastolic dysfunction in spontaneous type 2 diabetes rhesus monkeys: a study using echocardiography and magnetic resonance imaging |
| Q52870512 | Diastolic dysfunction is not related to changes in glycaemic control over 6 months in type 2 (non-insulin-dependent) diabetes mellitus |
| Q42439109 | Early alterations in myocardia and vessels of the diabetic rat heart: an FTIR microspectroscopic study. |
| Q68162961 | Effects of combined renovascular hypertension and diabetes mellitus on myocardial cells, non-vascular interstitium and capillaries: a stereological study on rat hearts |
| Q48623192 | Evaluation of the Right Ventricular Function in Prediabetes: A 2-D Speckle Tracking Echocardiographic Study. |
| Q24635109 | Feeding a protein-restricted diet during pregnancy induces altered epigenetic regulation of peroxisomal proliferator-activated receptor-α in the heart of the offspring |
| Q28251696 | GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes |
| Q38083574 | Glucose-induced cell signaling in the pathogenesis of diabetic cardiomyopathy |
| Q36766997 | Heart failure in sub-Saharan Africa: a literature review with emphasis on individuals with diabetes |
| Q36072601 | How to best manage glycemia and non-glycemia during the time of acute myocardial infarction |
| Q41653529 | Hypertension and pathologic cardiovascular remodeling: a potential therapeutic role for T-type calcium antagonists |
| Q42456255 | Hypertensive diabetic cardiomyopathy in the rat: ultrastructural features |
| Q35863637 | Hypertensive-diabetic cardiomyopathy in the rat: an experimental model of human disease |
| Q41545943 | Hypothesis: Is congestive cardiomyopathy caused by a hyperreactive myocardial microcirculation (Microvascular spasm)? |
| Q28577919 | Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue |
| Q35240672 | Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease |
| Q48722498 | Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients |
| Q26775037 | Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy |
| Q36664118 | Is it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes? |
| Q46578044 | Left ventricular diastolic function in normotensive type-2 diabetic subjects |
| Q48514398 | Left ventricular relaxation and filling pattern in diabetic heart muscle disease: an echocardiographic study |
| Q37101896 | Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis |
| Q77291970 | Maternally transmitted susceptibility to non-insulin-dependent diabetes mellitus and left ventricular hypertrophy |
| Q34623687 | Metabolic abnormalities in the diabetic heart |
| Q71939715 | Myocardial dysfunction and abnormal left ventricular exercise response in autonomic diabetic patients |
| Q46616771 | No correlation between the p38 MAPK pathway and the contractile dysfunction in diabetic cardiomyocytes: hyperglycaemia-induced signalling and contractile function |
| Q70463868 | Observations on atrial natriuretic peptide, sympathetic activity and renal Ca2+ pump in diabetic and hypertensive rats |
| Q72830355 | Pathomorphologic aspects of muscular tissue in diabetes mellitus |
| Q36736431 | Patient selection and vitamin E treatment in diabetes mellitus |
| Q46732505 | Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients |
| Q37402793 | Present Insights on Cardiomyopathy in Diabetic Patients |
| Q37113661 | Prevalence and significance of cardiometabolic risk factors in children with type 1 diabetes |
| Q71745271 | Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy |
| Q71884251 | Prognostic significance of diabetes mellitus in patients with acute myocardial infarction after recanalization |
| Q35581940 | Relation between aortic stiffness and left ventricular diastolic function in patients with hypertension, diabetes, or both |
| Q37899085 | Role of various proteases in cardiac remodeling and progression of heart failure |
| Q41356713 | Synergistic effects of diabetes mellitus and renovascular hypertension on the rat heart--stereological investigations on papillary muscles |
| Q41463315 | The cardiomyopathy of Wilson's disease. Myocardial alterations in nine cases |
| Q35125079 | The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults |
| Q43636295 | The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study |
| Q35625320 | The role of exercise in the treatment of cardiovascular disease associated with type 2 diabetes mellitus |
| Q54917687 | Theoretical overview of clinical and pharmacological aspects of the use of etelcalcetide in diabetic patients undergoing hemodialysis. |
| Q48390243 | Thrombospondin-1: the good, the bad, and the complicated |
| Q30389310 | Using basic fibroblast growth factor nanoliposome combined with ultrasound-introduced technology to early intervene the diabetic cardiomyopathy |
| Q68055622 | Vectorcardiographic evaluation of diabetic cardiomyopathy and of its contributing factors |
| Q69631165 | [Stress testing of long-term type I diabetic patients with radionuclide ventriculography] |